A leading charity says new Hepatitis C drug Sovaldi is a huge step forward in treating the disease – but says its high price means it is not affordable for use on the NHS. Gilead's Sovaldi ...

Sovaldi (sofosbuvir) offers a cure to most patients with the potentially life-threatening Hepatitis C infection, and also cuts treatment time and side-effects compared to existing drugs.